Home
BLTE

BLTE

Belite Bio Inc

as of 12-09-2025 3:58pm EST

$148.92

$0.99

-0.66%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Chart Type:

Time Range:

Founded:	2018	Country:	United States
Employees:	N/A	City:	N/A
Market Cap:	4.1B	IPO Year:	2022
Target Price:	$149.00	AVG Volume (30 days):	244.0K
Analyst Decision:	Strong Buy	Number of Analysts:	6
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-1.93	EPS Growth:	N/A
52 Week Low/High:	$49.00 - $160.55	Next Earning Date:	11-10-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered BLTE Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 68.92%

68.92%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full BLTE Forecast & Prediction with Hourly Data

Compare BLTE vs Leading Stocks

See how BLTE stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free BLTE Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "BLTE Belite Bio Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.